使用抗菌药物对婴幼儿肠道微生态的影响

doi:10.3969/j.issn.1673-8640.2018.08.021

检验医学 ›› 2018, Vol. 33 ›› Issue (8): 764-767.DOI: 10.3969/j.issn.1673-8640.2018.08.021

使用抗菌药物对婴幼儿肠道微生态的影响

苏思婷, 温洪宇, 袁振亚, 王秀颖, 王国振, 俞晨洁

江苏师范大学生命科学学院,江苏徐州 221116

收稿日期:2017-08-22 出版日期:2018-08-10 发布日期:2018-09-07
作者简介:null
作者简介：苏思婷,女,1997年生,主要从事细菌耐药机制研究。
基金资助:
江苏省大学生创新创业训练计划项目（201710320106X）;2017年度徐州市推动科技创新项目（KC17082）;江苏师范大学生命科学学院“十二五”专业综合改革试点项目（239）

Influence of antibiotic use on intestinal microecology of infants

SU Siting, WEN Hongyu, YUAN Zhenya, WANG Xiuying, WANG Guozhen, YU Chenjie

School of Life Science,Jiangsu Normal University,Xuzhou 221116,Jiangsu,China

Received:2017-08-22 Online:2018-08-10 Published:2018-09-07

摘要/Abstract

摘要：

人体肠道微生态中含有大量细菌,这些细菌对于人类健康具有重要的作用。目前,抗菌药物已经成为最常用的药物之一。抗菌药物的使用增加了某些疾病的患病风险,尤其是婴幼儿时期使用抗菌药物会导致肠道微生态失衡。近年来,围绕抗菌药物对肠道微生态的影响开展的研究越来越多。文章就抗菌药物给婴幼儿肠道微生态带来的影响作一综述。

关键词: 肠道微生态, 婴幼儿, 耐药性, 耐药基因

Abstract:

Human intestinal microecology has a vast number of bacteria,which plays a critical role in human health. At present,it is generally accepted that antibiotics have been one of the most common drugs in the world,and antibiotic use is associated with increasing risk for several diseases. Antibiotic use during infancy will induce imbalance in intestinal microecology,which is called dysbiosis. In the recent years,more and more researches have been known about the influence of antibiotics on intestinal microecology of infants. This review summarizes the effects of antibiotics on intestinal microecology of infants.

Key words: Intestinal microecology, Infants, Drug resistance, Drug resistance gene

中图分类号:

R446.5

苏思婷, 温洪宇, 袁振亚, 王秀颖, 王国振, 俞晨洁. 使用抗菌药物对婴幼儿肠道微生态的影响[J]. 检验医学, 2018, 33(8): 764-767.

SU Siting, WEN Hongyu, YUAN Zhenya, WANG Xiuying, WANG Guozhen, YU Chenjie. Influence of antibiotic use on intestinal microecology of infants[J]. Laboratory Medicine, 2018, 33(8): 764-767.

参考文献 24

[1]	BÄUMLER A J,SPERANDIO V. Interactions between the microbiota and pathogenic bacteria in the gut[J]. Nature,2016,535(7610):85-93.
[2]	VIKRAM A,KIM Y R,KUMAR S,et al.Vascular microRNA-204 is remotely governed by the microbiome and impairs endothelium-dependent vasorelaxation by downregulating Sirtuin1[J]. Nat Commun,2016,7:12565.
[3]	KORPELA K,SALONEN A,VIRTA L J,et al.Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children[J]. Nat Commun,2016,7:10410.
[4]	GIBSON M K,WANG B,AHMADI S,et al.Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome[J]. Nat Microbiol,2016,1:16024.
[5]	YIN X,GU X,YIN T,et al.Study of enteropathogenic bacteria in children with acute diarrhoea aged from 7 to 10 years in Xuzhou,China[J]. Microb Pathog,2016,91:41-45.
[6]	YASSOUR M,VATANEN T,SILJANDER H,et al. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability[J]. Sci Transl Med,2016,8(343):343ra81.
[7]	GASPARRINI A J,CROFTS T S,GIBSON M K,et al.Antibiotic perturbation of the preterm infant gut microbiome and resistome[J]. Gut Microbes,2016,7(5):443-449.
[8]	FOUHY F,OGILVIE L A,JONES B V,et al.Identification of aminoglycoside and β-lactam resistance genes from within an infant gut functional metagenomic library[J]. PLoS One,2014,9(9):e108016.
[9]	ALICEA-SERRANO A M,CONTRERAS M,MAGRIS M,et al. Tetracycline resistance genes acquired at birth[J]. Arch Microbiol,2013,195(6):447-451.
[10]	MALONE K M,GORDON S V.Antibiotic methylation:a new mechanism of antimicrobial resistance[J]. Trends Microbiol,2016,24(10):771-772.
[11]	KLEMM E,DOUGAN G.Advances in understanding bacterial pathogenesis gained from whole-genome sequencing and phylogenetics[J]. Cell Host Microbe,2016,19(5):599-610.
[12]	BOKULICH N A,CHUNG J,BATTAGLIA T,et al. Antibiotics,birth mode,and diet shape microbiome maturation during early life[J].Sci Transl Med,2016,8(343):343ra82.
[13]	NOBEL Y R,COX L M,KIRIGIN F F,et al.Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment[J]. Nat Commun,2015,6:7486.
[14]	DETHLEFSEN L,RELMAN D A.Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation[J]. Proc Nat Acad Sci U S A,2011,108(Suppl 1):4554-4561.
[15]	RUTTEN N B,RIJKERS G T,MEIJSSEN C B,et al.Intestinal microbiota composition after antibiotic treatment in early life:the INCA study[J]. BMC Pediatr,2015,15:204.
[16]	BAILEY L C,FORREST C B,ZHANG P,et al.Association of antibiotics in infancy with early childhood obesity[J]. JAMA Pediatr,2014,168(11):1063-1069.
[17]	SAARI A,VIRTA LJ,SANKILAMPI U,et al.Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life[J]. Pediatrics,2015,135(4):617-626.
[18]	TRASANDE L,BLUSTEIN J,LIU M,et al.Infant antibiotic exposures and early-life body mass[J]. Int J Obes(Lond),2013,37(1):16-23.
[19]	HARTSTRA A V,NIEUWDORP M,HERREMA H.Interplay between gut microbiota,its metabolites and human metabolism:dissecting cause from consequence[J]. Trends Food Sci Tech,2016,57:233-243.
[20]	SCHEITHAUER T P,DALLINGA-THIE G M,DE VOS W M,et al.Causality of small and large intestinal microbiota in weight regulation and insulin resistance[J]. Mol Metab,2016,5(9):759-770.
[21]	KORPELA K,SALONEN A,VIRTA L J,et al.Association of early-life antibiotic use and protective effects of breastfeeding:role of the intestinal microbiota[J]. JAMA Pediatr,2016,170(8):750-757.
[22]	PAOLELLA G,VAJRO P.Childhood obesity,breastfeeding,intestinal microbiota,and early exposure to antibiotics:what is the link?[J]. JAMA Pediatr,2016,170(8):735-737.
[23]	WANG L.ω3 and ω6 fatty acids:role in the body fat gain and development of obesity[J]. Chin J Hypertens,2015,23(1):7-15.
[24]	LAXMINARAYAN R,AMÁBILE-CUEVAS C F,CARS O,et al. UN high-level meeting on antimicrobials-what do we need?[J]. Lancet,2016,388(10041):218-220.

使用抗菌药物对婴幼儿肠道微生态的影响

Influence of antibiotic use on intestinal microecology of infants

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 24

相关文章 15

编辑推荐

Metrics

[1]	朱昱蓉, 张丹, 贺雅星, 李晶晶, 黄晶, 李婷, 刘鹏, 刘荣华. 肺炎克雷伯菌临床分离株分子分群和流行病学特征[J]. 检验医学, 2023, 38(5): 435-440.
[2]	方咏梅, 章燕, 徐雪莹, 钟峰. 金黄色葡萄球菌耐药性与耐药基因和毒力基因的相关性[J]. 检验医学, 2023, 38(4): 357-361.
[3]	王佳玮, 朱威南, 陈颖盈, 季萍, 王颖. 血培养分离碳青霉烯类耐药肺炎克雷伯菌临床分布和耐药基因分析[J]. 检验医学, 2023, 38(4): 362-367.
[4]	任燕飞, 张敏, 杨涛, 李荣凯, 梁新. 呼吸重症科患者下呼吸道感染病原菌流行病学分析[J]. 检验医学, 2023, 38(2): 157-162.
[5]	邓晨, 戴家泽, 邱丽红, 沈威廷, 蔡木发, 罗文英. 湛江地区高毒力肺炎克雷伯菌分子流行特征[J]. 检验医学, 2023, 38(11): 1026-1031.
[6]	杨思敏, 轩乾坤, 羽晓瑜, 温冬华, 李广波. 国产某品牌大肠埃希菌和肺炎克雷伯菌及3种碳青霉烯耐药基因试剂性能验证[J]. 检验医学, 2023, 38(1): 56-59.
[7]	朱丰村, 曾云祥, 金晓立, 曾添, 黄天鹏, 林枝, 周林双. 204株碳青霉烯类耐药肠杆菌目细菌耐药性分析[J]. 检验医学, 2023, 38(1): 60-65.
[8]	李若梅, 周银娣. 2019—2021年某教学医院无菌体液样本分离真菌临床分布及耐药性变迁[J]. 检验医学, 2022, 37(8): 757-760.
[9]	王建英, 王珊珊, 朱俊, 黄晓春, 万玉香, 刘云. 肺癌患者化疗后肺部感染病原菌分布及耐药性分析[J]. 检验医学, 2022, 37(4): 356-359.
[10]	孙英, 李轶, 闫文娟, 荆楠, 马冰. 河南地区少见CRE耐药性分析及碳青霉烯酶初筛实验的临床应用[J]. 检验医学, 2022, 37(2): 146-149.
[11]	赵晓敏, 江晓宇, 单凯莉, 单铁英, 刘秀珍. 缺铁性贫血患儿Flt-3L、TF、25（OH）D检测的临床意义[J]. 检验医学, 2022, 37(11): 1039-1043.
[12]	宋皓月, 舒文. 肉芽肿性乳腺炎患者结核硬脂酸棒状杆菌毒力因子和耐药性分析[J]. 检验医学, 2022, 37(11): 1075-1078.
[13]	王婧婧, 吴林清, 陈如寿, 王玉丰. 耐万古霉素肠球菌耐药基因、转座子结构和多位点序列分析[J]. 检验医学, 2021, 36(9): 891-895.
[14]	和平安, 陆衍舟, 杨旭, 吕梅, 夏晴, 李庆蓉. 烧伤灶感染病原菌及其耐药性随住院时间变迁的研究进展[J]. 检验医学, 2021, 36(9): 973-975.
[15]	张冠怡, 姚冬婷, 王健, 胡晓波. 光滑念珠菌耐药机制及中西药治疗光滑念珠菌感染研究进展[J]. 检验医学, 2021, 36(7): 761-765.